Tag Archives: immune pharmaceuticals

Immune Pharmaceuticals Inc (NASDAQ:IMNP) just announced that it has appointed a new chairman of its board of directors, but the company has remained relatively flat on the release. Markets seem to have overlooked the appointment, not just from...

Earlier this month, we highlighted Immune Pharmaceuticals Inc (NASDAQ:IMNP) as a potential biotechnology exposure, and asked ourselves the question, is there any value in a holding? Our conclusion was as follows: there is value there, so long...

At the end of first quarter 2014, Immune Pharmaceuticals Inc (NASDAQ:IMNP) traded for just shy of $4.50 a share. During the 36 or so months since, the company has declined to trade at current levels below $0.2 a share – a more than 95% decline...

Immune Pharmaceuticals Inc (NASDAQ:IMNP) is a big runner this week, up more than 55% on its Monday open. The company announced back on November 22 that it will host an R&D update event on December 8, and it looks as though someone is loading...

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter